Scandinavian ChemoTech AB Stock price

Equities

CMOTEC B

SE0009242654

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 07:03:33 2024-03-28 am EDT 5-day change 1st Jan Change
2.1 SEK +0.96% Intraday chart for Scandinavian ChemoTech AB -3.67% -22.22%
Sales 2023 2.82M 264K Sales 2024 * 5M 467K Capitalization 37.67M 3.52M
Net income 2023 -21M -1.96M Net income 2024 * -19M -1.78M EV / Sales 2023 15.6 x
Net Debt 2023 * 4M 374K Net cash position 2024 * 6.2M 579K EV / Sales 2024 * 6.29 x
P/E ratio 2023
-1.73 x
P/E ratio 2024 *
-3 x
Employees 6
Yield 2023 *
-
Yield 2024 *
-
Free-Float 62.57%
More Fundamentals * Assessed data
Dynamic Chart
Scandinavian ChemoTech AB Signs New Agreement with Chhatrapati Shivaji Subharti Hospital & Medical College CI
Scandinavian ChemoTech AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Scandinavian ChemoTech AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Scandinavian ChemoTech AB Receives Order for USD 30,000 from One of Its Largest Clients in the United States CI
Transcript : Scandinavian ChemoTech AB - Special Call
Scandinavian ChemoTech's Animal Care Division Receives an Order from A Leading Veterinary Hospital in South Florida, USA CI
Scandinavian ChemoTech Expects to Sign Three New Commercial Contracts in Fourth of 2023 CI
Scandinavian Chemotech Thanks for the Cooperation with Its IR Consultant Who Leaves the Management Team CI
Scandinavian ChemoTech AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Scandinavian Chemotech AB Animal Care Division Receives Additional Order from Existing Customer CI
Scandinavian ChemoTech's Subsidiary for Animal Care in the USA Receives Additional Orders for TSE Treatment Kits CI
Scandinavian Chemotech Foresees Higher Future Revenues After Signing A Third Commercial Contract in India CI
Scandinavian Chemotech Signs Distribution Agreement for Chile with Lambertis Corporation Sa CI
Scandinavian ChemoTech AB Expands its Cooperation with Gamma Gurus Pty Ltd in Australia to Include Human Care CI
Scandinavian ChemoTech AB's Subsidiary VQ Anim Care e Inc. Receives Order Confirmation for a VeterinaryIQure System to Ohio CI
More news

Latest transcript on Scandinavian ChemoTech AB

1 day+0.96%
1 week-3.67%
Current month-19.85%
1 month-23.64%
3 months-16.67%
6 months-28.81%
Current year-22.22%
More quotes
1 week
1.85
Extreme 1.85
2.49
1 month
1.85
Extreme 1.85
3.05
Current year
1.76
Extreme 1.76
5.20
1 year
1.64
Extreme 1.635
7.98
3 years
1.64
Extreme 1.635
41.00
5 years
1.64
Extreme 1.635
41.00
10 years
1.64
Extreme 1.635
84.00
More quotes
Managers TitleAgeSince
Founder 50 14-12-31
Director of Finance/CFO 58 -
Chief Tech/Sci/R&D Officer - 22-10-05
Members of the board TitleAgeSince
Chairman 51 19-12-31
Director/Board Member 71 19-12-31
Director/Board Member 71 19-12-31
More insiders
Date Price Change Volume
24-03-28 2.1 +0.96% 17,155
24-03-27 2.08 +3.48% 64,733
24-03-26 2.01 +0.50% 21,593
24-03-25 2 -6.98% 47,679
24-03-22 2.15 -2.71% 7,867

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:03 am EDT

More quotes
Scandinavian ChemoTech AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused on cancer treatment and manufactures specialized medical equipment. The Company's product IQWave is an electrochemotherapy (ECT) device. The IQWave system enhances the effects of the chemotherapeutic substance by opening up small pores in the tumor cells, giving the injected chemotherapeutic substance (no more than 15 IU of bleomycin) direct access to the DNA of the target cells. Among the product's applications are hypernephroma, kaposi sarcoma, transitional cell carcinoma, head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma. The treatment can be used for cutaneous as well as subcutaneous tumors.
Calendar
More about the company

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Scandinavian ChemoTech AB - Nasdaq Stockholm